study of calcarea phos 6x along with vitamin d supplementation for improving and maintaining vitamin d levels in people with low vitamin d

INTERVENTION: Intervention1: Calcarea Phosphorica 6 Xas an adjuvant to Vitamin D supplementation: Calcarea phosphorica 6 Xwith Vitamin D3 (cholecalciferol) & Calcarea phosphorica 6X‐ 4 tablets orally three times daily, along with Vitamin D3 60,000 IU orally once weekly, for 12 weeks. Control Intervention1: calcarea phos 6 X& vitamin d supplementation: Participants randomized to the intervention arm will receive Calcarea phosphorica 6 Xas an adjunct to Vitamin D supplementation according to the predefined study protocol for the specified treatment duration Participants randomized to the comparator arm will receive Vitamin D supplementation alone according to the predefined study protocol for the specified treatment duration. Control Intervention2: calcarea phos 6 Xas an adjuvant to vitamin d supplementation: Vitamin D3 (cholecalciferol)‐ 60,000 IU orally once weekly for 12 weeks. Along with rubrum 4 pills, twice a day morning and evening. CONDITION: Health Condition 1: E559‐ Vitamin D deficiency, unspecified PRIMARY OUTCOME: To evaluate the efficacy of Calcarea Phosphorica 6X in the management of Hypovitaminosis D and to observe the improvement and sustainability in serum Vitamin D levels in both groups. ; ; ‐To compare the efficacy of Calcarea Phosphorica 6X as an adjuvant to Vitamin D supplementation alone. ; ; Timepoint: 2‐3 months SECONDARY OUTCOME: To evaluate the improvement in physical well‐ being and musculoskeletal symptoms of the patientTimepoint: 2‐3 months INCLUSION CRITERIA: patients of both sexes, aged eighteen to 50 years with vitamin d deficiency.